Description
Presenter: Dr. Brian Pilecki
Overview.
This webinar will explore diverse models of care within the rapidly evolving field of psychedelic medicine, examining their unique approaches, requirements, and implications for patient access. We will discuss four primary models: the psychedelic-assisted therapy model employed in clinical research settings, the prescriber model emphasizing medical oversight, the peer support and community-based care, model and the facilitator model currently implemented under state-legalized programs in Oregon and Colorado.
The session will define and examine harm reduction and integration therapy approaches, which provide therapeutic support for clients who choose to use psychedelics outside of clinical settings. A critical analysis of ongoing debates surrounding practitioner training requirements, scope of practice, and the evolving roles of therapists, facilitators, and monitors will be presented, with particular attention to balancing clinical safety with treatment feasibility and accessibility.
Key topics will include: comparative analysis of training standards across models, regulatory considerations and their impact on service delivery, ethical frameworks for different practice contexts, and strategies for ensuring equitable access to psychedelic treatments. The webinar will conclude with an exploration of interdisciplinary team considerations, including optimal team compositions, screening for health risks and collaborative care approaches that enhance patient outcomes while addressing the complex needs of this emerging field.
Objectives.
- Assess the four models of psychedelic care
- Identify ongoing debates surrounding practitioner training standards and roles in psychedelic medicine.
- Describe the use of harm reduction and integration therapy for clients using psychedelics on their own.
About the Presenter.
Brian Pilecki, PhD: Dr. Brian Pilecki is the Clinical Services Manager and an Associate Scientist at the Portland Institute of Psychedelic Science, a subsidiary of Portland Psychotherapy Therapy Clinic, Research, and Training Center. He is an active researcher and a study therapist on several clinical trials including the investigation of the use of MDMA-assisted therapy for the treatment of social anxiety disorder. Brian is also an instructor for Fluence, a leading psychedelic training organization where he provides training to psilocybin facilitators in state-level programs or to study therapists in clinical trials across the country. He is co-founder of Perspective Retreats which offers group psilocybin retreats in the Netherlands, and founder of Entropia which provides psilocybin facilitation to individuals and groups in the state of Oregon. Brian is a co-founder of Portland Integration Network, a network of professionals offering specialized care related to psychedelics in Oregon. He is also the author of the book ACT-Informed Exposure for Anxiety and co-host of Altered States of Context, a podcast about psychotherapy and psychedelics.
CE Information
1 hour of CE
Cost
FREE